Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| GLD-M609 | Human | Monoclonal Anti-HSV-2-Glycoprotein D Antibody, Human IgG1 (3H9) |
|
||
| GLD-Y111 | Mouse | Monoclonal Glycoprotein D (HSV-2) Antibody, Mouse IgG1 (3H9) |
|
||
| GLD-V52H4 | HSV-2 | HSV-2 (strain 333) Envelope Glycoprotein D (gD), His Tag (MALS verified) |  |
|
|
Immobilized HSV-2 (strain HG52) Envelope Glycoprotein D (gD), His Tag (MALS verified) (Cat. No. GLD-V52H4) at 2 μg/mL (100 μL/well) can bind Monoclonal Glycoprotein D (HSV-2) Antibody, Mouse IgG1 (3H9) (Cat. No. GLD-Y111) with a linear range of 0.195-6.25 ng/mL (QC tested).
The purity of HSV-2 (strain 333) Envelope Glycoprotein D (gD), His Tag (Cat. No. GLD-V52H4) is more than 90% and the molecular weight of this protein is around 40-55 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| UB-621 | UB-621 | Phase 2 Clinical | United Biopharma Inc | Herpes Simplex; Herpes Genitalis | Details |
This web search service is supported by Google Inc.
A-Z
